Review Linked Higher FSH Levels to Bone and Brain Risks
Researchers found that follicle-stimulating hormone may impact health markers in midlife women beyond fertility.
Updated on Sept. 22, 2026 in Nutrition
Live Poll
Do you trust emerging health research markers over traditional diagnostic tests for managing your health?
A review published in September 2026 in the Journal of Clinical Medicine suggests that FSH plays a broader physiological role than previously recognized. The findings indicate that rising levels of the hormone may be linked to changes in bone density and brain health in women aged 30 to 70.
Why it matters
Authors argue that current clinical practice overlooks FSH as an early signal for endocrine changes that impact longevity. This perspective shift may change how physicians assess risks related to bone and cognitive health in midlife.
The peer-reviewed review analyzed decades of research, including the SWAN cohort and imaging data from 191 midlife women. Findings revealed that each doubling of FSH is associated with a 39% greater risk of lumbar spine bone loss within one year.
The players
Dr. Deanna Minich
A researcher with 25 years of experience who received the 2025 Linus and Ava Helen Pauling Award.
The details
FSH receptors have been identified in various tissues, including the brain, bone, fat, blood vessels, and kidneys. Researchers posit that FSH activity in these areas may drive physiological changes as levels rise, such as beta-amyloid deposition in brain regions associated with Alzheimer's risk and a decrease in lean muscle mass. While animal studies suggest that blocking FSH could reduce total body fat, human applications remain under investigation.
Timeline
September 2026: Publication of the review in the Journal of Clinical Medicine.
Health Landscape
This review integrates data from the SWAN cohort to challenge traditional endocrine models that focus solely on reproductive status. It marks a shift toward viewing FSH as an active physiological regulator throughout midlife.
If you are concerned about shifts in your bone density or cognitive health during midlife, it is worth discussing your hormone profiles with your doctor. Tracking symptoms and discussing the relevance of FSH levels with a physician can help you better understand your personal health risks.
The takeaway
FSH is increasingly viewed as a hormone with systemic effects beyond the reproductive system. Consider tracking your bone health and discussing potential risk factors for bone loss with your physician during routine midlife checkups.
Further reading
For more information on the evolving understanding of hormonal health, visit our Nutrition section.
More information
Review the full findings and associated materials on the Symphony Natural Health menopause research portal.
Source note: This article includes information reported by The Herald Journal.
Live Poll
Do you trust emerging health research markers over traditional diagnostic tests for managing your health?
